Gaviscon Mint, Kautabletten - 8 Tablette(n) Swissmedic Key 62889001 Registration Holder Reckitt Benckiser (Switzerland) AG Name Gaviscon Mint, Kautabletten Date of registration 05.06.2013 Introduction of Sequence 05.06.2013 ATC-Classification Antacids, Other Combinations (A02AX) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 8 Tablette(n) Index Therapeuticus (Swissmedic) 04.01. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680628890011 Medication Code Synthetika Pharmacode Disponibility
Composition natrii alginas 250 mg, natrii hydrogenocarbonas 133.5 mg, calcii carbonas 80 mg, mannitolum, macrogolum 20'000, magnesii stearas, copovidonum, aspartamum 3.75 mg, acesulfamum kalicum, aromatica (Pfefferminz) cum E 220, pro compresso corresp. natrium 63.16 mg. Packungsbestandteile Galenic Form Chewing tablets Active Agent Dose Calcium Carbonate 80 mg Sodium Alginate 250 mg Sodium Hydrogen Carbonate 133.5 mg
Inactive agents Dose Acesulfamum Kalicum Aromatica (Pfefferminz) cum E 220 Aspartame 3.75 mg Copovidonum Macrogol 20000 Magnesii Stearas Mannitol Pro Compresso
Source Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
